Digestive Remedies in South Korea

Publication Date	May 2009
Publisher	Euromonitor
Product Type	Report
Pages	30
ISBN Number	not applicable
Product Code	EUR00767

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Digestive Remedies in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

Indigestion and heatburn remedies, laxatives, diarrhoeal remedies, motion sickness remedies, child-specific digestive remedies

Data coverage:

market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the digestive remedies industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Digestive Remedies in South Korea
Euromonitor International
May 2009
List of Contents and Tables
- Executive Summary
- Continued Slowdown in 2008
- More OTC Products Are Expected To Switch To Quasi-drugs
- Fast Growth of the Rx Market Hinders Growth of OTC Healthcare
- Active Movement in New Product Developments and the Acquisition of Patents
- Product Margins for Pharmacists Affect Sales of OTC Products
- Key Trends and Developments
- Manufacturers' Efforts in Research and the Acquisition of Patents
- Economy Slowdown Affects OTC Healthcare in Korea
- More OTC Healthcare Products Are Expected To Switch To Quasi-drugs
- Distribution Channels Are More Diverse During the Review Period
- Suppliers Appease Pharmacists With High Margins
- Market Indicators
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Market Data
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
- OTC Registration and Classification
- Vitamins & Dietary Supplements Registration and Classification
- Self-medication and Preventative Medicine
- Generics
- Switches
- Definitions
Summary 1 Research Sources
- Daewoong Pharmaceutical Co Ltd
- Strategic Direction
- Key Facts
Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics 2007
- Competitive Positioning
Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2008
- Dong Wha Pharmaceutical Industrial Co Ltd
- Strategic Direction
- Key Facts
Summary 6 Dong Wha Pharmaceutical Industrial Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Industrial Co Ltd: Operational Indicators
- Company Background
- Production
Summary 8 Dong Wha Pharmaceutical Industrial Co Ltd: Production Statistics
- Competitive Positioning
Summary 9 Dong Wha Pharmaceutical Industrial Co Ltd: Competitive Position 2008
- Dong-a Pharmaceutical Co Ltd
- Strategic Direction
- Key Facts
Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
- Company Background
- Production
Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics
- Competitive Positioning
Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2008
- Kwang Dong Pharm Co Ltd
- Strategic Direction
- Key Facts
Summary 14 Kwang Dong Pharm Co Ltd: Key Facts
Summary 15 Kwang Dong Pharm Co Ltd: Operational Indicators
- Company Background
- Production
Summary 16 Kwang Dong Pharm Co Ltd: Production Statistics 2008
- Competitive Positioning
Summary 17 Kwang Dong Pharm Co Ltd: Competitive Position 2008
- Sk Chemicals Co Ltd
- Strategic Direction
- Key Facts
Summary 18 SK Chemicals Co Ltd: Key Facts
Summary 19 SK Chemicals Co Ltd: Operational Indicators
- Company Background
- Production
Summary 20 SK Chemicals Co Ltd: Production Statistics
- Competitive Positioning
Summary 21 SK Chemical Co Ltd: Competitive Position 2008
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Data
- Table 11 Sales of Digestive Remedies by Subsector: Value 2003-2008
- Table 12 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
- Table 13 Herbal vs Standard Digestive Remedies 2003-2008
- Table 14 Digestive Remedies Company Shares by Value 2004-2008
- Table 15 Digestive Remedies Brand Shares by Value 2005-2008
- Table 16 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
- Table 17 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013